Cite

    Ikonomidis, I. et al. (n.d.). Beta-amyloid and mitochondrial-derived peptide-c are additive predictors of adverse outcome to high-on-treatment platelet reactivity in type 2 diabetics with revascularized coronary artery disease. European heart journal. p. . [Online].